Areda Bilisuma G, Gizaw Solomon T, Berdida Delesa H, Kebalo Abbul H
Department of Medical Biochemistry, School of Medicine, College of Health Sciences Haramaya University Haramaya Ethiopia.
Department of Medical Biochemistry, School of Medicine, College of Health Sciences Addis Ababa University Addis Ababa Ethiopia.
Health Sci Rep. 2022 Sep 1;5(5):e806. doi: 10.1002/hsr2.806. eCollection 2022 Sep.
Pregnancy-induced hypertension is one of the top three ranked diseases during pregnancy that cause maternal, fetal, and neonatal morbidity and mortality worldwide. To provide adequate information to clinicians and researchers who are striving for potential interventions, biochemical profiling of such patients is required.
A hospital-based case-control study design was conducted from August 2020 to May 2021 to evaluate serum lipid profile, uric acid, and high sensitivity C-reactive protein (hs-CRP) among women with pregnancy-induced hypertension compared to normotensive pregnant women. Data were entered and analyzed using SPSS version 25. Independent -test and were used to compare the relationship of variables between the two groups. A -value less than 0.05 was used to test statistical significance.
The result of this study showed that while the levels (mean ± SD) of serum total cholesterol (TC), triglyceride (TG), low-density lipoprotein-cholesterol (LDL-C), TC/high-density lipoprotein-cholesterol (HDL-C), TG/HDL-C, LDL-C/HDL-C were significantly elevated, HDL-C was decreased among women with pregnancy-induced hypertension than normotensive pregnant women ( < 0.0001). The levels (mean ± SD) of uric acid and hs-CRP were significantly higher among women with pregnancy-induced hypertension compared to normotensive pregnant women ( < 0.0001).
This study indicated that pregnancy-induced hypertension women have lipid abnormalities, increased systemic inflammatory markers, and hyperuricemia compared to normotensive pregnant women. Thus, women with PIH showing high dyslipidemia, hyperuricemia, and inflammation are likely to develop hypertension. Therefore, evaluation of these potential biomarkers during early antenatal care services may help seek interventions in PIH.
妊娠高血压是全球孕期导致孕产妇、胎儿和新生儿发病及死亡的三大主要疾病之一。为向致力于寻求潜在干预措施的临床医生和研究人员提供充分信息,需要对此类患者进行生化分析。
于2020年8月至2021年5月开展了一项基于医院的病例对照研究,以评估妊娠高血压妇女与血压正常的孕妇相比的血脂谱、尿酸和高敏C反应蛋白(hs-CRP)情况。使用SPSS 25版录入并分析数据。采用独立样本t检验和方差分析来比较两组变量之间的关系。P值小于0.05用于检验统计学显著性。
本研究结果显示,与血压正常的孕妇相比,妊娠高血压妇女的血清总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白胆固醇(LDL-C)、TC/高密度脂蛋白胆固醇(HDL-C)、TG/HDL-C、LDL-C/HDL-C水平显著升高,而HDL-C降低(P<0.0001)。与血压正常的孕妇相比,妊娠高血压妇女的尿酸和hs-CRP水平显著更高(P<0.0001)。
本研究表明,与血压正常的孕妇相比,妊娠高血压妇女存在血脂异常、全身炎症标志物升高和高尿酸血症。因此,患有妊娠高血压且血脂异常、高尿酸血症和炎症严重的妇女可能会发展为高血压。因此,在早期产前护理服务期间评估这些潜在生物标志物可能有助于寻求对妊娠高血压的干预措施。